Intra-Cellular Therapies Highlights Lumateperone Bipolar Depression Data Presentations at the 2022 International Society for Bipolar Disorders (ISBD) Experience
Source:
Nasdaq GlobeNewswire
/
13 Jun 2022 08:00:01 America/New_York
N/A
Share on,